PharmiWeb.com - Global Pharma News & Resources
19-Dec-2018

5-HT2C Antagonist - Pipeline Insight 2018 - ResearchAndMarkets.com

The "5-HT2C Antagonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'5-HT2C Antagonist - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Antagonist development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for 5-HT2C Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. 5-HT2C Antagonist - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for 5-HT2C Antagonist

4. Comparative Analysis

5. 5-HT2C Antagonist Pipeline Products in Clinical Stages

6. 5-HT2C Antagonist Pipeline Products in Non-clinical Stages

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

Companies Mentioned

  • Fabre-Kramer Pharmaceuticals
  • Sumitomo Dainippon Pharma
  • AnaMar AB
  • Lundbeck A/S
  • S1 Pharmaceuticals
  • Altus Formulation Inc
  • Servier
  • Janssen-Cilag

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/lp8tts/5ht2c_antagonist?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005351/en/

Editor Details

Last Updated: 19-Dec-2018